Srivastava 2.jpeg (IMAGE)

Texas Tech University Health Sciences Center

Srivastava 2.jpeg

Caption

Sanjay Srivastava, Ph.D., recently received a U.S. patent for repurposing pimavanserin to treat various types of cancer.

Credit

TTUHSC

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.